Literature DB >> 4909360

Controlled trial of phenobarbitone in neonatal jaundice.

G E Levin, G P McMullin, A N Mobarak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4909360      PMCID： PMC2020397          DOI： 10.1136/adc.45.239.93

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  12 in total

1.  Reduction in concentration of total serum-bilirubin in offspring of women treated with phenobarbitone during pregnancy.

Authors:  H M Maurer; J A Wolff; M Finster; P J Poppers; E Pantuck; R Kuntzman; A H Conney
Journal:  Lancet       Date:  1968-07-20       Impact factor: 79.321

2.  Barbiturate and hyperbilirubinaemia of prematurity.

Authors:  W Walker; M I Hughes; M Barton
Journal:  Lancet       Date:  1969-03-15       Impact factor: 79.321

3.  Clinical experience with phenobarbitone in icterus neonatorum.

Authors:  M D Cunningham; J W Mace; E R Peters
Journal:  Lancet       Date:  1969-03-15       Impact factor: 79.321

4.  Effect of phenobarbitone on low-birth-weight infants.

Authors:  R J Robinson
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

5.  Phenobarbitone and neonatal jaundice.

Authors:  G P McMullin
Journal:  Lancet       Date:  1968-11-02       Impact factor: 79.321

6.  Controlled trials of phenobarbitone therapy of neonatal jaundice.

Authors:  C Ramboer; R P Thompson; R Williams
Journal:  Lancet       Date:  1969-05-10       Impact factor: 79.321

Review 7.  Phenobarbital in the perinatal period.

Authors:  J T Wilson
Journal:  Pediatrics       Date:  1969-03       Impact factor: 7.124

8.  Reduction in serum bilirubin by phenobarbital in adult unconjugated hyperhilirubinaemia. Is enzyme induction responsible?

Authors:  M J Whelton; L P Krustev; B H Billing
Journal:  Am J Med       Date:  1968-07       Impact factor: 4.965

9.  Enhancement of glucuronide-conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital.

Authors:  S J Yaffe; G Levy; T Matsuzawa; T Baliah
Journal:  N Engl J Med       Date:  1966-12-29       Impact factor: 91.245

10.  Effect of sodium phenobarbital on bilirubin metabolism in an infant with congenital, nonhemolytic, unconjugated hyperbilirubinemia, and kernicterus.

Authors:  J F Crigler; N I Gold
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808
View more
  6 in total

1.  [Prevention of morbus haemolyticus neonatorum and of transitory hyperbilirubinemias of newborn infants through an enzyme inductor combination].

Authors:  H W Kintzel
Journal:  Blut       Date:  1973-05

2.  Relative roles of phototherapy and phenobarbitone in treatment of nonhaemolytic neonatal jaundice.

Authors:  Y K Wong; B S Wood
Journal:  Arch Dis Child       Date:  1973-09       Impact factor: 3.791

3.  Barbiturate treatment of neonatal icterus.

Authors:  A Dortmann; H Haupt; F Küster
Journal:  Z Kinderheilkd       Date:  1972

4.  Phenobarbitone in neonatal jaundice.

Authors:  D Sinniah; L K Tay; A E Dugdale
Journal:  Arch Dis Child       Date:  1971-10       Impact factor: 3.791

Review 5.  Yinzhihuang oral liquid in the treatment of neonatal jaundice: a meta-analysis.

Authors:  Jie Zeng; Su-Jun Wang; Yong-Mei Li; Hang-Shan Li; Qian Luo; Yun-Ying Huang; Qun Jiang; Li Wang
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

6.  Phenobarbital and Phototherapy Combination Enhances Decline of Total Serum Bilirubin and May Decrease the Need for Blood Exchange Transfusion in Newborns with Isoimmune Hemolytic Disease.

Authors:  Mahmoud Af Kaabneh; Ghassan Sa Salama; Ayoub Ga Shakkoury; Ibrahim Mh Al-Abdallah; Afrah Alshamari; Ruba Aa Halaseh
Journal:  Clin Med Insights Pediatr       Date:  2015-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.